Turning Data into Action for Colorectal Cancer November 17, 2014 Jessica Shaffer, Director, Maine CDC Colorectal Cancer Control Program www.mainecancerconsortium.org.

Slides:



Advertisements
Similar presentations
2004 Camden County Cancer Capacity and Needs Assessment: The Next Steps Jean F. Mouch, MD, MPH Camden County Coalition Coordinator April 6, 2005.
Advertisements

THE COMMONWEALTH FUND Source: McCarthy and Leatherman, Performance Snapshots, Percentage of Community-Dwelling Adults Ages.
THE COMMONWEALTH FUND Source: McCarthy and Leatherman, Performance Snapshots, Data: National Health Interview Survey (National.
Behavioral Risk Factor Surveillance System
Diabetes in Idaho BRFSS 2009 Data collected from Behavioral Risk Factor Surveillance System Idaho Department of Health and Welfare, Division of.
Behavioral Risk Factor Surveillance System (BRFSS) Contributors: Wayne A. Honey, MPH Jennifer E. Daniel, MPH Annie Hickman, BS Survey Unit, Injury & Behavioral.
Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer
The National Comprehensive Cancer Control Program (NCCCP): Current Progress and Future Action Temeika L. Fairley, Epidemiologist Comprehensive Cancer Control.
Sex Differences in the Prevalence and Correlates of Colorectal Cancer Testing: Health Information National Trends Survey Sally W. Vernon 1, Amy.
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.
Cancer Statistics 2013 A Presentation from the American Cancer Society
Cancer Prevention in Taiwan
Haley Hyde Jessica Fordham Jena Hamm  Colorectal cancer is a leading cause of cancer related deaths every year.  150,000 Americans will be diagnosed.
D EPARTMENT of F AMILY M EDICINE Colon Cancer Screening in Iowa Barcey T. Levy, PhD, MD Professor, Family Medicine and Epidemiology University of Iowa.
Healthy People 2010 Focus Area 3 Cancer Progress Review October 16, 2002.
Chronic Disease in Missouri: Progress and Challenges Shumei Yun, MD, PhD Public Health Epidemiologist and Team Leader Chronic Disease and Nutritional Epidemiology.
Colorectal Cancer in Kentucky Trends and Geographic Variation Presented by Thomas C. Tucker, PhD, MPH Associate Professor Department of Epidemiology.
DHHS Office of Civil Rights Title VI Training Conference Philadelphia, PA August 13, 2002 Using Data to Identify Disparities: Issues, Limitations, Cautions.
S Bhagwandin, DO COLORECTAL CANCER PREVENTION. DEFINING ISSUE Colorectal cancer is almost 90% preventable with recommended screening- early detection.
Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.
Disparities in Cancer September 22, Introduction Despite notable advances in cancer prevention, screening, and treatment, a disproportionate number.
Cancer Statistics 2013 A Presentation from the American Cancer Society
MOLLY SCHWENN, MD CANCER REGISTRY MAINE CDC, DHHS OCTOBER 25, 2013 Population-based Cancer Surveillance: State Perspective.
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
A Profile of Health among Massachusetts Adults: Highlights from the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS) Health Survey.
Regional Cancer Report Summary: Burlington, Camden and Gloucester Counties Jean F. Mouch, MD, MPH Hilary Dugger Colbert, MPA Camden County Coordinator.
Liesl Eathington Iowa Community Indicators Program Iowa State University October 2014.
Our Vision – Healthy Kansans Living in Safe and Sustainable Environments.
Women’s Health in Massachusetts Highlights from the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS): Health Survey Program Bureau.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
SEECP Health Ministerial Meeting Achievements and challenges of strenghtening health system performance through addressing inequalities in health services.
Barriers to Screening BCCEDP CRC Project. Iowa Breast and Cervical Cancer Early Detection Program Colon Cancer Education Pilot Project  Goal: Increase.
US Cancer Burden Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
Prevention and Health Promotion Administration May Overview of Colorectal Cancer Maryland Department of Health & Mental Hygiene Prevention and Health.
Community Health Needs Assessment Introduction and Overview Berwood Yost Franklin & Marshall College.
CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.
“The African American Prostate Cancer Crisis in Numbers”
Colorectal Cancer Screening in Appalachia PA: a pilot intervention project William Curry, MD, MS Dept of Family & Community Medicine M.S.Hershey Medical.
Alaska Native Tumor Registry Alaska Native Epidemiology Center 40-Year Trends in Cancer Incidence among Alaska Native People
Presented by Thomas C. Tucker, PhD, MPH Associate Director Markey Cancer Center Cancer Prevention and Control program University of Kentucky Associate.
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.
SUSAN G. KOMEN CENTRAL GEORGIA AFFILIATE WE LIVE HERE. WE RACE HERE. WE SAVE LIVES HERE.
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
PAIN CONTROL AMONG CANCER SURVIVORS IN OHIO 2010 Robert W. Indian, Chief Mary Lynn, Researcher Debbie Wallace, Administrative Assistant Comprehensive Cancer.
UPDATES AND OPPORTUNITIES Community Networks Program & CDC Grant – “Integrating Colorectal Cancer Screening with Chronic Disease Programs”
Factors Predicting Stage of Adoption for Fecal Occult Blood Testing and Colonoscopy among Non-Adherent African Americans Hsiao-Lan Wang, PhD, RN, CMSRN,
Healthy People 2010 Focus Area 3 Cancer Progress Review October 16, 2002.
Colorado Colorectal Screening Program Holly Wolf University of Colorado School of Medicine
Healthy People 2010 Focus Area 3: Cancer Progress Review August 17, 2006.
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
OZAUKEE COUNTY COMMUNITY HEALTH SURVEY – March 2012 Commissioned by: Aurora Health Care Children’s Hospital of Wisconsin Columbia St. Mary’s Health System.
New Links to Colorectal Cancer Prevention American Cancer Society Wellmark Foundation.
Copyright © 2008 Delmar. All rights reserved. Chapter 4 Epidemiology and Public Health Nursing.
What does the data tell us? Colorectal CANCER IN NEVADA
Colorectal Cancer Screening Guidelines
The Burden of Colorectal Cancer in Arkansas
Learn about different types of diabetes
Colorectal Cancer Screening, Medicare and Disability
Evidence of a Program's Effectiveness in Improving Colorectal Cancer Screening Rates in Federally Qualified Health Centers Robert L. Stephens, PhD, MPH1;
Trends in Colorectal Cancer Screening Among Maryland Residents Age 65 and Older Maryland Cancer Survey, Presented by: Carolyn Poppell, MS University.
SAMPLE – Preliminary Results
Colorectal Cancer: National and International Perspective on the Burden of Disease and Public Health Impact  Ziad F. Gellad, Dawn Provenzale  Gastroenterology 
Exhibit 1 Blacks More Likely Than Whites to Lack a Usual Source of Care & Forgo Care Because of Costs Percent: Adults who went without care because of.
The Research Question Flexible sigmoidoscopy (FS) is the only cancer screening modality (for any type of cancer) to reduce all-cause mortality compared.
1994 Methodology The percent of U.S. adults who are obese or who have diagnosed diabetes was determined by using data from the Behavioral Risk Factor Surveillance.
Colorectal cancer survival disparities in California
Recent Incidences and Trends of the Top Cancers in Northeast Tennessee Appalachian Region Adekunle Oke1, Sylvester Orimaye2, Ndukwe Kalu1, Dr. Faustine.
Presentation transcript:

Turning Data into Action for Colorectal Cancer November 17, 2014 Jessica Shaffer, Director, Maine CDC Colorectal Cancer Control Program Tim Cowan, Director, Health Index Initiative

 Five-year funding through US CDC ( ).  One-year extension funding ( ).  In collaboration with four largest health systems in Maine. Program goals:  Direct provision of screening and diagnostic services to underserved populations.  Increase population screening rates through implementation of evidence-based policy & systems initiatives. “Integrating Colorectal Cancer Screening in Chronic Disease”

*Year 06 screening goal = > 200 screenings

Colorectal Cancer Incidence and Mortality Decreasing Over Time

CRC Incidence & Mortality among CRCCP States, 2010 a a Incidence rates are per 100,000 and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P ). (Source: Combined data from the National Program of Cancer Registries as submitted to CDC by November 2012 and from the Surveillance, Epidemiology, and End Results program submitted to National Cancer Institute in November 2012.) a Mortality rates are per 100,000 and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P ). (Source: U.S. Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention, 2014.)

BRFSS Methodology Changes Sampling method changes Addition of cell phone users to increase coverage of respondents with lower income, lower educational levels and of younger age groups Weighting method changes Better adjustment for demographic differences between respondents and the actual population by including additional demographic variables in the weighting method Due to these changes, BRFSS data from 2011 forward will not be directly comparable to data from previous years

Operational Definitions FOBT - Fecal Occult Blood Test within the past 1 year Colonoscopy - Colonoscopy within past 10 years FS + FOBT - Flexible sigmoidoscopy within the past 5 years with FOBT within the past 3 years Combined - FOBT within the past year; or flexible sigmoidoscopy within the past 5 years and FOBT within the past 3 years; or colonoscopy within the past 10 years

Colorectal Screening Prevalence, 2012 a a Percentages reported for adults aged years. (Source: Behavioral Risk Factor Surveillance System, Department of Health and Human Services, Centers for Disease Control and Prevention, 2012.)

CRC Screening Prevalence by CRCCP States, 2012 a a Combined. Percentages reported for adults aged years. (Source: Behavioral Risk Factor Surveillance System, Department of Health and Human Services, Centers for Disease Control and Prevention, 2012.)

CRC Screening by Gender, 2012 a a Percentages reported for adults aged years. (Source: Behavioral Risk Factor Surveillance System, Department of Health and Human Services, Centers for Disease Control and Prevention, 2012.)

CRC Screening by Age, 2012 a a Combined. Percentages reported for adults aged years. (Source: Behavioral Risk Factor Surveillance System, Department of Health and Human Services, Centers for Disease Control and Prevention, 2012.) Data are suppressed if groups have fewer than 50 observations.

CRC Screening by Income, 2012 a a Combined. Percentages reported for adults aged years. (Source: Behavioral Risk Factor Surveillance System, Department of Health and Human Services, Centers for Disease Control and Prevention, 2012.) Data are suppressed if groups have fewer than 50 observations.

CRC Screening by Insurance Status, 2012 a a Combined. Percentages reported for adults aged years. (Source: Behavioral Risk Factor Surveillance System, Department of Health and Human Services, Centers for Disease Control and Prevention, 2012.) Data are suppressed if groups have fewer than 50 observations.

CRC Screening by Maine County, 2012

Five-year Relative Survival Rates Top Five Cancers All Stages LocalRegionalDistant Lung/Bronchus* Colon/Rectum Breast-Female Uterine Cervix Prostate * screening test available only for those with high-risk

Stage of Cancers Diagnosed Cancer/SEER Stats vs MaineU.S. Whites Early-stage (in-situ or localized) 47%45%40%43% Late-stage (regional or distant cancers) 47%49%55%52% Unknown Stage 6% 5% Total 100%

Evidence-Based Interventions: FIT Testing Randomized Control Trial in 16 Rural Family Medicine Offices in Iowa Intervention Number of Patients (743 total) % screened for colorectal cancer (any type) Usual Care % Physician chart reminder % Physician reminder + mailed educational materials & FIT % Physician reminder + mailed educational materials & FIT + Telephone call % JABFM, September-October 2013, Vol. 26 No. 5; p doi: /jabfm

Randomized Control Trial- 16 Rural FM Offices in Iowa JABFM, September-October 2013, Vol. 26 No. 5; p doi: /jabfm Percent Screened with fecal immunochemical test (FIT) or colonoscopy (CS)

U.S. CDC: Screen for Life: The Community Guide: Maine CDC Cancer Screening: Additional Resources

Jessica Shaffer Thank You! Tim Cowan